1. Table of Content
2. Executive Summary
3. Global Autoimmune Disease Diagnostics Market Introduction
3.1. Global Autoimmune Disease Diagnostics Market – Taxonomy
3.2. Global Autoimmune Disease Diagnostics Market –Definitions
3.2.1. Type
3.2.2. Disease
3.2.3. End User
4. Global Autoimmune Disease Diagnostics Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
4.5. Global Autoimmune Disease Diagnostics Market Dynamic Factors - Impact Analysis
4.6. Global Autoimmune Disease Diagnostics Market – Competition Landscape
4.7. Epidemiology
5. Global Autoimmune Disease Diagnostics Market Analysis,2015 - 2019 and Forecast, 2020 – 2026
5.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
5.3. Market OpportunityAnalysis
6. Global Autoimmune Disease Diagnostics Market, By Type, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
6.1. Systemic Autoimmune Disease
6.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Local Autoimmune Disease
6.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Autoimmune Disease Diagnostics Market Forecast, By Disease,2015 - 2019 and Forecast, 2020 – 2026
7.1. Diabetes Type-1
7.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Rheumatoid Arthritis
7.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Multiple Sclerosis
7.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Autoimmune Disease Diagnostics Market Forecast, By End User, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
8.1. Diagnostic Centers
8.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Hospitals
8.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Research Laboratories
8.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Autoimmune Disease Diagnostics Market Forecast, By Region, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Autoimmune Disease Diagnostics Market - Opportunity Analysis Index, By Type, By Disease, By End User and Region, 2020 – 2026
10. North America Autoimmune Disease Diagnostics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
10.1. Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Systemic Autoimmune Disease
10.1.2. Local Autoimmune Disease
10.2. Disease Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Diabetes Type-1
10.2.2. Rheumatoid Arthritis
10.2.3. Multiple Sclerosis
10.2.4. Others
10.3. End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Diagnostic Centers
10.3.2. Hospitals
10.3.3. Research Laboratories
10.3.4. Others
10.4. Country Analysis 2016 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. U.S.
10.4.2. Canada
10.5. North America Autoimmune Disease Diagnostics Market - Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026
10.6. North America Autoimmune Disease Diagnostics Market Dynamics – Trends
11. Europe Autoimmune Disease Diagnostics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
11.1. Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Systemic Autoimmune Disease
11.1.2. Local Autoimmune Disease
11.2. Disease Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Diabetes Type-1
11.2.2. Rheumatoid Arthritis
11.2.3. Multiple Sclerosis
11.2.4. Others
11.3. End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Diagnostic Centers
11.3.2. Hospitals
11.3.3. Research Laboratories
11.3.4. Others
11.4. Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Germany
11.4.2. UK
11.4.3. France
11.4.4. Spain
11.4.5. Italy
11.4.6. Russia
11.4.7. Poland
11.4.8. Rest of Europe
11.5. Europe Autoimmune Disease Diagnostics Market - Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026
11.6. Europe Autoimmune Disease Diagnostics Market Dynamics – Trends
12. Asia-Pacific Autoimmune Disease Diagnostics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
12.1. Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Systemic Autoimmune Disease
12.1.2. Local Autoimmune Disease
12.2. Disease Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Diabetes Type-1
12.2.2. Rheumatoid Arthritis
12.2.3. Multiple Sclerosis
12.2.4. Others
12.3. End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Diagnostic Centers
12.3.2. Hospitals
12.3.3. Research Laboratories
12.3.4. Others
12.4. Country Analysis2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Japan
12.4.2. China
12.4.3. India
12.4.4. ASEAN
12.4.5. Australia & New Zealand
12.4.6. Rest of Asia-Pacific
12.5. Asia-Pacific Autoimmune Disease Diagnostics Market - Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026
12.6. Asia-Pacific Autoimmune Disease Diagnostics Market Dynamics – Trends
13. Latin America Autoimmune Disease Diagnostics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
13.1. Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Systemic Autoimmune Disease
13.1.2. Local Autoimmune Disease
13.2. Disease Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Diabetes Type-1
13.2.2. Rheumatoid Arthritis
13.2.3. Multiple Sclerosis
13.2.4. Others
13.3. End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Diagnostic Centers
13.3.2. Hospitals
13.3.3. Research Laboratories
13.3.4. Others
13.4. Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Argentina
13.4.4. Venezuela
13.4.5. Rest of Latin America
13.5. Latin America Autoimmune Disease Diagnostics Market - Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026
13.6. Latin America Autoimmune Disease Diagnostics Market Dynamics – Trends
14. Middle East and Africa Autoimmune Disease Diagnostics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
14.1. Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
14.1.1. Systemic Autoimmune Disease
14.1.2. Local Autoimmune Disease
14.2. Disease Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Diabetes Type-1
14.2.2. Rheumatoid Arthritis
14.2.3. Multiple Sclerosis
14.2.4. Others
14.3. End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Diagnostic Centers
14.3.2. Hospitals
14.3.3. Research Laboratories
14.3.4. Others
14.4. Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.4.1. Gulf Cooperation Council (GCC) Countries
14.4.2. Israel
14.4.3. South Africa
14.4.4. Rest of MEA
14.5. MEA Autoimmune Disease Diagnostics Market - Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026
14.6. MEA Autoimmune Disease Diagnostics Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Beckman Coulter, Inc. (U.S.)
15.2.2. Abbott Laboratories (U.S.)
15.2.3. F. Hoffmann-La Roche Ltd. (Switzerland)
15.2.4. bioMerieux SA (France)
15.2.5. Siemens AG (Siemens Healthineers) (Germany)
15.2.6. Inova Diagnostics Inc. (Werfen Life Group, S.A.(Spain)
15.2.7. Bio-Rad Laboratories (U.S.)
15.2.8. MBL International Corporation (U.S.)
15.2.9. Quest Diagnostics Inc. (U.S.).
16. Research Methodology
17. Key Assumptions and Acronyms
18. Disclaimer
19. The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.